The announcement of the 85th review meeting of the Shenzhen Stock Exchange listing review committee in 2023 reveals that the initial public offering (IPO) application of Bellen Chemistry Co., Ltd. has been approved by the Listing Committee. The company is

Jul 2, 2023, Bellen Chemistry Co., Ltd. Yantai site received the Drug Production License issued by the Shandong Medical Products Administration (License code: Lu 20230014). This is the first time that Bellen has

2022Corporate Social responsibility -Bellen Chemistry Co., Ltd. Yantai.pdf

Bellen Chemistry Co., Ltd. (referred to as Bellen) recently completed the company's headquarters relocation, which aims to improve the company's research and development working environment. Since the beginning of 2022, Bellen moved fr